Local chemotherapy of cutaneous neoplasms.
D000230:Adenocarcinoma / Q000188:drug therapy; D000486:Allergy and Immunology; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D003609:Dactinomycin / Q000627:therapeutic use; D005354:Fibrosarcoma / Q000188:drug therapy; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D006967:Hypersensitivity; D007938:Leukemia / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D008545:Melanoma / Q000188:drug therapy; D008727:Methotrexate / Q000627:therapeutic use; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000188:drug therapy*; D014228:Triaziquone / Q000627:therapeutic use
D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D003609:Dactinomycin; D014228:Triaziquone; D005472:Fluorouracil; D008727:Methotrexate